Comprehensive metabolome analyses reveal N acetylcysteine responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin Metabolomics Springer Nature Link Current treatments for systemic lupus erythematosus (SLE) include glucocorticoids, antimalarial agents, immunosuppressants, and biologic agents, but safer and more effective therapies are needed. Telitacicept, a new dual inhibitor of the cytokines B Diseases Linked to LOW GLUTATHIONE Glutathione: Master Antioxidant, Reducing Oxidative Stress, and Detoxification Dysregulated neutrophilic cell death in SLE: a spotlight on ferroptosis Signal Transduction and Targeted Therapy